T&T Expected to Receive COVID-19 Vaccines From South Korea


T&T Expected to Receive COVID-19 Vaccines From South Korea

The AstraZeneca antibodies for T&T from the COVAX office are being produced in South Korea are as yet on target regardless of a new attack on an Italian stockroom where AstraZeneca immunizations were housed.

This was affirmed in Parliament by Health Minister Terrence Deyalsingh yesterday. He gave the affirmation when asked by UNC MP Saddam Hosein about the new attack of an AstraZeneca antibody office in Italy and whether this would defer the shipment of immunizations to T&T through the COVAX office. The antibodies in Italy were reserved for lower and center pay nations through COVAX too.

Deyalsingh said, “I’m sorry to disappoint my friends opposite (UNC).”

He said he, just as the Prime Minister, Chief Medical Officer and PAHO had said a few times that the antibodies T&T’s getting from COVAX in the primary case are made at an AstraZeneca plant in South Korea. He said that was as yet on target.

On Hosein’s different inquiries, Deyalsingh said Government has no information—at this point in time—that future shipments of the remaining 77,000 vaccines for T&T might be delayed.”

He said, “The other 77,000 doses, according to COVAX and PAHO, are on stream at this time to be delivered by May… we don’t have an exact date but COVAX and PAHO have committed to supplying us by the end of May.”

On Thursday, PAHO affirmed that T&T initial cluster of antibodies through the COVAX office is planned to show up on March 31st.